Hey Forrest yep read your posts, hence I thought it worth...

Hey Forrest yep read your posts, hence I thought it worth pointing out on this one, as generally your research seems spot on, and just wondering if I missed something. But having gone back over the prospectus, these are the key points I believe. They have only just produced grams, not kilograms, no production facilities and no commercial market yet? They may well be very close to achieving commercialising as per below, but just was getting confused as to the investment proposition of this one, as it seems a long way back compared to some other Ostana companies

• Dotz entered into the Rice University Licence Agreement in December 2014, and since then has spent approximately US$902,000 further developing the technology by scaling up the production from nano-sized samples to gram sized samples that have been sent to potential customers for evaluation. Dotz is continuing to work with these potential customers to achieve commercialisation of its GQDs.
• Phase 1: Establishment of production facilities for the development of manufacturing protocols for specific GQD applications and manufacturing of large scale commercial samples of GQDs (i.e. kilogram sized samples). Dotz' current laboratory facilities are not suitable for this purpose.
• There is no current commercial market for Dotz produced GQDs. While current QDs are suitable for use in the conventional QD market (such as healthcare, displays and lighting), it is in the unconventional and ‘low specification’ application QD markets that Dotz has recognised a potential unique selling point for market entry. Moving forward, the Company plans to focus on this ‘low end market during the initial stages of Dotz business development, then move to cater to the ‘conventional QD market’ at a later stage (pending that focus being commercially worthwhile andwhether further implementation of technological development is successful).